The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA), met with Presidential Candidate Giorgos Lillikas, within the framework of its meetings with the presidential candidates. “We had a very substantive dialogue with Mr. Lillikas...
The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) expresses the belief that the change in the pricing policy for medicines, as has been approved by Cabinet, ensures, under the circumstances, the continued availability of the majority...
Did you know that it takes on average 12 years for a new medicine to get from the lab to the shelves of your Pharmacy? Did you know that only 5 in every 5.000 compounds that enter the preclinical testing phase actually make it to human testing? Did you know that only...
*by Jacqueline Anastassiades Innovation in the pharmaceutical sector is a characteristic of medical progress in general and has contributed dramatically to increasing population survival or improving disease management. Innovation is present in all sectors of economic...
The foundation for creating a network for research and innovation in Cyprus has been set by the meeting for the European Innovative Medicines Initiative (IMI) programme, held on July 3, at the Cyprus Institute of Neurology and Genetics. With a budget of €2 billion,...
